Where does Auspex Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Auspex Pharmaceuticals, Inc. ranks #7,117 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Auspex Pharmaceuticals, Inc. hold?

Auspex Pharmaceuticals, Inc. holds 46 US utility patents granted between 2015 and 2024, spanning 7 technology areas.

What is Auspex Pharmaceuticals, Inc.'s Innovation Score?

Auspex Pharmaceuticals, Inc. has an Innovation Score of 42.4 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Auspex Pharmaceuticals, Inc. focus on?

Auspex Pharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 42 patents, ranking #535 of 7,163 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Auspex Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Auspex Pharmaceuticals, Inc.'s recent grant velocity is -36% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Auspex Pharmaceuticals, Inc.'s patents?

Auspex Pharmaceuticals, Inc.'s patents average 23.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Auspex Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Auspex Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 46 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Auspex ranks #7,117 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 7 technology areas.

#7,117
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.4/100): 23.6
avg claims per patent: -36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7117 · US Corporation #7,117 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,117/49,997
PHOTO-FINISH Aerie Pharmaceuticals
CPC-NARROW A61K · 7 areas
INNOV-PAR 42.4/100
CLAIMS-DENSE 23.6 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aerie Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Auspex’s 42.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (31%) Velocity 5.6 pts (13%) Breadth 9.4 pts (22%) Claim depth 14.1 pts (33%)

Qualcomm Incorporated · highest

85
Auspex Pharmaceuticals · this assignee

42
Piramal Pharma · near

42
QSC · near

42
The Vollrath L L C · near

42
Zimmer Biomet Spine · near

42
3D Lighting… · lowest

7

What this shows Auspex's Innovation Score is 42.4/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Auspex?

Each dot is one of Auspex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Auspex’s own 23.6 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Auspex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Auspex's grants concentrate

Auspex Pharmaceuticals, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 91.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (13 grants) versus a trough of 2 in 2018. By volume, Auspex sits between Aerie Pharmaceuticals, Inc. and Breeo, LLC.

Auspex's three-year grant acceleration

Auspex Pharmaceuticals, Inc. shows 10 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aerie Pharmaceuti…

46
Anton Paar

46
Araxes Pharma

46
Artisan Vehicle S…

46
Avive Solutions

46
Binj Laboratories

46
Bradshaw Internat…

46
Breeo

46
Auspex Pharmaceut… ◀

46

What this shows Auspex holds 46 patents at rank #7,117, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Auspex

By rank, the assignees closest to #7,117 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Auspex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Auspex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Auspex ranks #535 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

QSC, LLC 42 The Vollrath Company, L.L.C. 42 Zimmer Biomet Spine, Inc. 42 Piramal Pharma Limited 42

Auspex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Auspex Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	13.0%
2016	13	28.3%
2017	3	6.5%
2018	2	4.3%
2019	4	8.7%
2020	4	8.7%
2021	4	8.7%
2022	4	8.7%
2023	4	8.7%
2024	2	4.3%

Which technologies does Auspex Pharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 42

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 41

C07D - Heterocyclic Compounds 31

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 28

C07C - Acyclic OR Carbocyclic Compounds 8

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Auspex Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Auspex Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 91.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #7,117 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Auspex Pharmaceuticals, Inc. against Aerie Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.